CAG
DGX icon

Csenge Advisory Group’s Quest Diagnostics DGX Stock Holding History

Csenge Advisory Group’s Portfolio DGX Stock Details DGX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2017
Q4 		– Sell
-6,561
Closed -$614K – 258
2017
Q3 		$614K Buy
+6,561
New +$697K 0.24% 100

Other funds holding DGX

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Macquarie Group
Macquarie Group Sydney, NSW 2000, Australia $16.8B AUM 27.39% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Victory Capital Management
Victory Capital Management San Antonio, Texas $156B AUM 27.51% 1-Year Est. Return
Allianz Asset Management
Allianz Asset Management Munich, Germany $95.4B AUM 38.74% 1-Year Est. Return
Bessemer Group
Bessemer Group Woodbridge, New Jersey $63.6B AUM 28.76% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
FMI
Fiduciary Management Inc Milwaukee, Wisconsin $8.06B AUM 6.78% 1-Year Est. Return
American Century Companies
American Century Companies Kansas City, Missouri $194B AUM 35% 1-Year Est. Return

Csenge Advisory Group's DGX Position: Q4 2017 in Review

Csenge Advisory Group sold out of Quest Diagnostics (DGX) in Q4 2017, closing a stake of 6,561 shares — an estimated $614K sold.

Csenge Advisory Group first reported a position in DGX in Q3 2017 and held it in 1 quarter. The position peaked at $614K in Q3 2017. 631 funds tracked by Wall St. Rank hold DGX as of Q4 2017.

  • Csenge Advisory Group reported no remaining Quest Diagnostics position as of Q4 2017 after selling out during the quarter.
  • Csenge Advisory Group sold 6,561 Quest Diagnostics shares in Q4 2017, an estimated $614K.
  • Csenge Advisory Group first reported a position in Quest Diagnostics in Q3 2017 and held it in 1 quarter.
  • Csenge Advisory Group's Quest Diagnostics position peaked at $614K in Q3 2017.
  • 631 funds tracked by Wall St. Rank held Quest Diagnostics as of Q4 2017.

Based on Csenge Advisory Group's 13F filing for Q4 2017, filed 15 Feb 2018.